Rafael Holdings authorizes $5M share repurchase; expands strategic search beyond biopharma

Rafael Holdings, Inc.

Board authorized repurchase of up to $5M of Class B common stock.
Company to seek investment opportunities within and beyond biopharma.
CEO cites balance sheet strength and confidence in long-term value creation.
Repurchases may be through open market or private transactions, subject to conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.